Methyl-CpG binding domain protein 3-like 3 (MBD3L3)

Methyl-CpG binding domain protein 3-like 3 (MBD3L3) is a putative methyl-CpG-binding domain protein encoded by the MBD3L3 gene in humans. It is predicted to play a role in **DNA methylation-dependent heterochromatin formation** and possibly the **negative regulation of transcription** by RNA polymerase II, based on homology and predicted protein function. Like other members of the methyl-CpG-binding domain family, it is believed to localize mainly to the **nucleus**. Unlike well-characterized MBD proteins (such as MBD2 or MBD3), little functional and mechanistic data are available for MBD3L3 specifically, and it has not been established as a direct therapeutic target or disease biomarker. MBD3L3 is primarily defined bioinformatically and through gene/protein family association, with no evidence for direct interaction with drugs or use in therapeutic settings[1][6][7][4]. **Notes:** - There is no evidence in current literature or databases indicating that MBD3L3 is a therapeutic target, receptor, enzyme, or similar protein; therefore, *is_target* is set to "false". - The protein is included in human genome annotations based on predicted function; supporting experimental detail is limited. - Its biological functions are predicted, not demonstrated, and most information is derived by analogy to other MBD proteins. - No specific drugs, biomarkers, or safety considerations are associated with MBD3L3 at this time[1][6].

Other names

MBD3L3MBD3-like protein 3MBD3-like 3Putative methyl-CpG-binding domain protein 3-like 3methyl-CpG-binding domain protein 3 like 3